Carevive recognizes the importance of including patient-reported outcomes into the care planning process, so they have developed surveys that will provide patients with the resources to address those concerns, according to Carrie Stricker, PhD, RN, AOCN, chief clinical officer and co-founder of Carevive.
Carevive recognizes the importance of including patient-reported outcomes into the care planning process, so they have developed surveys that will provide patients with the resources to address those concerns, according to Carrie Stricker, PhD, RN, AOCN, chief clinical officer and co-founder of Carevive.
Transcript (slightly modified)
Are you working on implementing programs that integrate patient-reported outcomes in care plans?
So, at the heart of what we do at Carevive is care planning, and since our very inception in 2013 we have been integrating patient-reported outcomes into our care planning process. My position prior to cofounding Carevive with another oncology nurse, I’m an oncology nurse practitioner and nurse scientist by background, but prior to founding Carevive back in 2013 I was director of clinical programs for survivorship at University of Pennsylvania’s Abramson Cancer Center along with Linda Jacobs, who was the whole program director.
Some of the work that I was doing there was integrating patient-reported symptoms and concerns into survivorship care planning to ensure that those care plans reflected what the patient thought was most important to them, and what was affecting their quality of life and their ability to engage with care most effectively. So when Carevive was birthed, at its very inception, integrating the patient voice—not only in symptoms, function, and concerns but also preferences and goals—into the process has been central.
So we do that through, we currently have a library of over 45 validated surveys that electronically patients can take, either at visits on a tablet or kiosk or desktop in the waiting room, or between visits on iPhones, smartphones, or home computers. And those symptoms or other outcomes, quality of life or other preferences and goals, are then processed by our algorithms that are evidence-based and present back to the patient advice and resources to address their own concerns and to incorporate that into their care plans and the coordination of that plan moving forward.
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Dr Al Benson on Reimbursement for Supportive Care When Treating Patients With Cancer
March 22nd 2024Al Benson, MD, FACP, FACCC, FASCO, medical oncologist at Northwestern University Feinberg School of Medicine and associate director of the Robert E. Tillery Comprehensive Cancer Center, discussed findings from a national survey assessing barriers to comprehensive cancer care delivery.
Read More
FDA Approves Tislelizumab for Advanced or Metastatic ESCC After Chemotherapy
March 15th 2024The FDA has approved tislelizumab-jsgr (Tevimbra) for single-agent use in adult patients with unresectable or metastatic esophageal squamous cell carcinoma following prior systemic chemotherapy that did not include a PD-1/PD-L1 inhibitor.
Read More